Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthamber Regulatory News (NAR)

Share Price Information for Northamber (NAR)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
23.00
Ask:
27.00
Spread: 4.00 (17.391%)
Market Cap: £6.78m
NAR Live PriceLast checked at - London Stock Exchange

Intraday Northamber Share Chart

Interim Management Statement

17 Nov 2011 15:54

RNS Number : 3200S
Northamber PLC
17 November 2011
 



17 November 2011

 

Northamber plc

Interim Management Statement

 

The results of the strategic refocus of the business model in my last update to shareholders and the repositioning of our vendor offerings, are starting to bear fruit. Sales in Q1 of the current financial year improved by some 9% over the Q4 sales to 30 June 2011.

 

However, as widely published, all volume product sectors continue to suffer significantly from reducing demand and resultant over-supply. Context's market analysis on European I.T. distribution stated that Q3 demand had decreased by 18% over 2010.

 

On our own volume product portfolio, we were not immune to the lower levels of demand. Consequential oversupply and commensurate vendor destocking actions adversely affected our overall margins. Despite having taken avoiding actions and our areas of success, overall gross profit margins of 6.5% for our July to September Q1 compared with 7.0% for last year as a whole.

 

The combination of de-positioning the empty-revenue portion of our volume portfolio offerings and the wider economic downturn resulted in a 29% reduction in total sales in Q1 to 30 September 2011 of this financial year compared with Q1 last year.

 

The effects of the significant falls in selling prices per unit of the oversupplied volume products has resulted in our costs of sale being a greater daily management challenge.

 

As always we operate very strict cost controls on every aspect of the business. Whilst continuing to work to bring the cost ratios back into line with our needs and expectations, since the start of 2011 the underlying uncertainties have presented additional challenges to the business.

 

Some pre-emptive significant cost savings have already been implemented and will be recognised in the second half of the current financial year, and beyond. However, the unabated pressures of the on-going challenges are keeping this subject at the forefront of our attentions.

 

The extent of the volume product sector downturn can best be assessed at the operating level where the loss in Q1 to 30 September 2011 of 1.6% of sales, compared with a profit of 0.4% of sales in Q1 last year and a near break-even level for last year as a whole.

 

After buying another 150,000 ordinary shares for treasury at a cost of £86,155, we continue to maintain a very high level cash balances, with zero borrowings. The cash balance at the end of Q1 this year was £9.08 million compared with £10.7 million at 30 June. Whilst the rates of interest remain at a consistent low level, the income from these balances is minimal.

 

Net Assets per share at 30 September 2011 were 85.2 pence per share, compared with 86.5 pence per share at the end of June 2011.

 

For the present, there is no clear indication of any early improvement in the industry outlook. Hopefully when the overstocking situation is resolved there may be a return to a more rational balance of product and pricing. In the meantime we can only continue to operate as efficiently and effectively as we can.

 

For further information please contact:

 

Northamber plc 020 8296 7000

David Phillips

 

FoxDavies Capital 020 3463 5000

Barry Saint

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKODPPBDDNDD
Date   Source Headline
18th Nov 20168:30 amRNSPosting of Annual Report
28th Oct 20167:00 amRNSFinal Results
13th Apr 201610:41 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSHalf Yearly Report
22nd Feb 201612:31 pmRNSDirectorate Change
12th Jan 20162:59 pmRNSDirectorate Change
15th Dec 20155:24 pmRNSResult of AGM
18th Nov 20154:40 pmRNSAnnual Report & Accounts
23rd Oct 20157:00 amRNSFinal Results
16th Oct 20157:00 amRNSChange of Adviser
12th Mar 20157:00 amRNSHalf Yearly Report
12th Nov 201412:43 pmRNSPosting of Annual Accounts
30th Oct 20147:00 amRNSFinal Results
7th Mar 20147:00 amRNSHalf Yearly Report
5th Nov 20137:00 amRNSPosting of Annual Report & Accounts
7th Oct 201311:56 amRNSFinal Results
2nd Sep 20138:00 amRNSCancellation Northamber Plc
1st Aug 201311:15 amRNSSchedule 1 - Northamber Plc
31st Jul 20133:40 pmRNSResult of General Meeting
4th Jul 201310:58 amRNSProposed move to AIM
15th May 20137:00 amRNSInterim Management Statement
27th Feb 20137:00 amRNSHalf Yearly Report
20th Dec 20121:25 pmRNSResult of AGM
28th Nov 20127:00 amRNSPosting of Annual Accounts
14th Nov 20127:00 amRNSInterim Management Statement
6th Nov 20127:00 amRNSChange of Adviser
27th Sep 20127:00 amRNSPreliminary Results for the YE 30 June 2012
18th Jul 201211:56 amRNSResult of Meeting
22nd Jun 20127:00 amRNSCirc re. shareholder meeting
26th Apr 20124:11 pmRNSInterim Management Statement
20th Apr 20125:41 pmRNSPurchase of Property
21st Feb 20122:47 pmRNSPurchase of Own Shares
21st Feb 20127:00 amRNSDirectorate Change
21st Feb 20127:00 amRNSHalf Yearly Report
17th Nov 20113:54 pmRNSInterim Management Statement
16th Nov 20115:37 pmRNSResult of AGM
27th Oct 20117:00 amRNSTransaction in Own Shares
23rd Sep 20118:23 amRNSTransaction in Own Shares
30th Aug 20114:49 pmRNSTransaction in Own Shares
26th Aug 20117:00 amRNSFinal Results
6th Jun 201110:02 amRNSHolding(s) in Company
1st Jun 20117:00 amRNSTransaction in Own Shares
16th May 20117:00 amRNSTransaction in Own Shares
12th May 20119:15 amRNSInterim Management Statement
22nd Feb 20117:00 amRNSInterim Statement
28th Jan 20117:00 amRNSChange of Adviser
22nd Dec 20102:10 pmRNSDirectorate Change
22nd Nov 20101:44 pmRNSTransaction in Own Shares
19th Nov 20104:14 pmRNSAGM Statement
12th Nov 20107:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.